Reduced vascular endothelial growth factor and capillary density in the occipital cortex in dementia with lewy bodies

Brain Pathology

Volumn 24, Issue 4, 2014, Pages 334-343

  Miners, Scott ^a   Moulding, Hayley ^a   De Silva, Rohan ^b   Love, Seth ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

dementia with Lewy bodies; factor VIII related antigen; hypoperfusion; oxygen gluocose deprivation; VEGF

Indexed keywords

ALPHA SYNUCLEIN; DIPEPTIDYL CARBOXYPEPTIDASE; ENDOTHELIN 1; GLUCOSE; MYELIN ASSOCIATED GLYCOPROTEIN; OXYGEN; VASCULOTROPIN; VON WILLEBRAND FACTOR; ENDOTHELIAL CELL GROWTH FACTOR; MAG PROTEIN, HUMAN; SNCA PROTEIN, HUMAN; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

AGED; ARTICLE; BRAIN; BRAIN BLOOD FLOW; CAPILLARY DENSITY; CLINICAL ARTICLE; CONTROLLED STUDY; DIFFUSE LEWY BODY DISEASE; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MICROVASCULATURE; NEUROBLASTOMA CELL; OCCIPITAL CORTEX; PERFUSION; VASOCONSTRICTION; CAPILLARY; CELL HYPOXIA; DEFICIENCY; GENETICS; METABOLISM; OCCIPITAL LOBE; PATHOLOGY; PHOSPHORYLATION; PHYSIOLOGY; TUMOR CELL LINE; VASCULARIZATION; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ALPHA-SYNUCLEIN; CAPILLARIES; CELL HYPOXIA; CELL LINE, TUMOR; ENDOTHELIAL GROWTH FACTORS; ENDOTHELIN-1; FEMALE; GLUCOSE; HUMANS; LEWY BODY DISEASE; MALE; MYELIN-ASSOCIATED GLYCOPROTEIN; OCCIPITAL LOBE; PEPTIDYL-DIPEPTIDASE A; PHOSPHORYLATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VON WILLEBRAND FACTOR;

EID: 84902655779     PISSN: 10156305     EISSN: 17503639     Source Type: Journal    
DOI: 10.1111/bpa.12130     Document Type: Article

References (65)

1. Anderson JP, Walker DE, Goldstein JM, de Laat R, Banducci K, Caccavello RJ, et al. (2006) Phosphorylation of Ser-129 is the dominant pathological modification of α-synuclein in familial and sporadic Lewy body disease. J Biol Chem 281: 29739-29752.
2. Ashby EL, Kehoe PG, Love S, (2010) Kallikrein-related peptidase 6 in Alzheimer's disease and vascular dementia. Brain Res 1363: 1-10.
3. Baptista MJ, O'Farrell C, Daya S, Ahmad R, Miller DW, Hardy J, et al. (2003) Co-ordinate transcriptional regulation of dopamine synthesis genes by α-synuclein in human neuroblastoma cell lines. J Neurochem 85: 957-968.
4. Barcia C, Bautista V, Sanchez-Bahillo A, Fernandez-Villalba E, Faucheux B, Poza y Poza M, et al. (2005) Changes in vascularization in substantia nigra pars compacta of monkeys rendered parkinsonian. J Neural Transm 112: 1237-1248.
5. Barker R, Ashby E, Wellington D, Barrow V, Palmer J, Kehoe PG, et al. (2014) Pathophysiology of white matter perfusion in Alzheimer's disease and vascular dementia. Brain doi: 10.1093/brain/awu040. In press.
6. Barker R, Wellington D, Esiri MM, Love S, (2013) Assessing white matter ischemic damage in dementia patients by measurement of myelin proteins. J Cereb Blood Flow Metab 33: 1050-1057.
7. Barua NU, Miners JS, Bienemann AS, Wyatt MJ, Welser K, Tabor AB, et al. (2012) Convection-enhanced delivery of neprilysin: a novel amyloid-β- degrading therapeutic strategy. J Alzheimers Dis 32: 43-56.
8. Bellucci A, Collo G, Sarnico I, Battistin L, Missale C, Spano P, (2008) -synuclein aggregation and cell death triggered by energy deprivation and dopamine overload are counteracted by D2/D3 receptor activation. J Neurochem 106: 560-577.
9. Borroni B, Perani D, Broli M, Colciaghi F, Garibotto V, Paghera B, et al. (2005) Pre-clinical diagnosis of Alzheimer disease combining platelet amyloid precursor protein ratio and rCBF spect analysis. J Neurol 252: 1359-1362.
10. Braak H, Alafuzoff I, Arzberger T, Kretzschmar H, Del Tredici K, (2006) Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry. Acta Neuropathol 112: 389-404.
11. Braak H, Del Tredici K, Rub U, de Vos RA, Jansen Steur EN, Braak E, (2003) Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 24: 197-211.
12. Brown DR, Hunter R, Wyper DJ, Patterson J, Kelly RC, Montaldi D, McCullouch J, (1996) Longitudinal changes in cognitive function and regional cerebral function in Alzheimer's disease: a SPECT blood flow study. J Psychiatr Res 30: 109-126.
13. Byrne EJ, Lennox G, Lowe J, Godwin-Austen RB, (1989) Diffuse Lewy body disease: clinical features in 15 cases. J Neurol Neurosurg Psychiatry 52: 709-717.
14. Chao LL, Buckley ST, Kornak J, Schuff N, Madison C, Yaffe K, et al. (2010) ASL perfusion MRI predicts cognitive decline and conversion from MCI to dementia. Alzheimer Dis Assoc Disord 24: 19-27.
15. Chen L, Feany MB, (2005) -synuclein phosphorylation controls neurotoxicity and inclusion formation in a Drosophila model of Parkinson disease. Nat Neurosci 8: 657-663.
16. Colloby SJ, Fenwick JD, Williams ED, Paling SM, Lobotesis K, Ballard C, et al. (2002) A comparison of (99 m)Tc-HMPAO SPET changes in dementia with Lewy bodies and Alzheimer's disease using statistical parametric mapping. Eur J Nucl Med Mol Imaging 29: 615-622.
17. de la Torre JC, (1999) Critical threshold cerebral hypoperfusion causes Alzheimer's disease? Acta Neuropathol 98: 1-8.
18. de la Torre JC, (2005) Is Alzheimer's disease preceded by neurodegeneration or cerebral hypoperfusion? Ann Neurol 57: 783-784.
19. Dickstein DL, Walsh J, Brautigam H, Stockton SD Jr, Gandy S, Hof PR, (2010) Role of vascular risk factors and vascular dysfunction in Alzheimer's disease. Mt Sinai J Med 77: 82-102.
20. Firbank MJ, Colloby SJ, Burn DJ, McKeith IG, O'Brien JT, (2003) Regional cerebral blood flow in Parkinson's disease with and without dementia. Neuroimage 20: 1309-1319.
21. Fong TG, Inouye SK, Dai W, Press DZ, Alsop DC, (2011) Association cortex hypoperfusion in mild dementia with Lewy bodies: a potential indicator of cholinergic dysfunction? Brain Imaging Behav 5: 25-35.
22. Guglielmotto M, Aragno M, Autelli R, Giliberto L, Novo E, Colombatto S, et al. (2009) The up-regulation of BACE1 mediated by hypoxia and ischemic injury: role of oxidative stress and HIF1α. J Neurochem 108: 1045-1056.
23. Holmes C, Cairns N, Lantos P, Mann A, (1999) Validity of current clinical criteria for Alzheimer's disease, vascular dementia and dementia with Lewy bodies. Br J Psychiatry 174: 45-50.
24. Hunya A, Foldi I, Szegedi V, Soos K, Zarandi M, Szabo A, et al. (2008) Differences between normal and α-synuclein overexpressing SH-SY5Y neuroblastoma cells after Aβ(1-42) and NAC treatment. Brain Res Bull 75: 648-654.
25. Iadecola C, (2003) Cerebrovascular effects of amyloid-β peptides: mechanisms and implications for Alzheimer's dementia. Cell Mol Neurobiol 23: 681-689.
26. Imran MB, Kawashima R, Awata S, Sato K, Kinomura S, Ono S, et al. (1999) Tc-99 m HMPAO SPECT in the evaluation of Alzheimer's disease: correlation between neuropsychiatric evaluation and CBF images. J Neurol Neurosurg Psychiatry 66: 228-232.
27. Ishii K, Yamaji S, Kitagaki H, Imamura T, Hirono N, Mori E, (1999) Regional cerebral blood flow difference between dementia with Lewy bodies and AD. Neurology 53: 413-416.
28. Ishimaru H, Ueda K, Takahashi A, Maruyama Y, (1998) Changes in presynaptic protein NACP/α-synuclein in an ischemic gerbil hippocampus. Brain Res 788: 311-314.
29. Johnson NA, Jahng GH, Weiner MW, Miller BL, Chui HC, Jagust WJ, et al. (2005) Pattern of cerebral hypoperfusion in Alzheimer disease and mild cognitive impairment measured with arterial spin-labeling MR imaging: initial experience. Radiology 234: 851-859.
30. Kalaria RN, Cohen DL, Premkumar DR, Nag S, LaManna JC, Lust WD, (1998) Vascular endothelial growth factor in Alzheimer's disease and experimental cerebral ischemia. Brain Res Mol Brain Res 62: 101-105.
31. Li L, Zhang X, Yang D, Luo G, Chen S, Le W, (2009) Hypoxia increases Aβ generation by altering β- and γ-cleavage of APP. Neurobiol Aging 30: 1091-1098.
32. Li W, Jiang H, Song N, Xie J, (2011) Oxidative stress partially contributes to iron-induced α-synuclein aggregation in SK-N-SH cells. Neurotox Res 19: 435-442.
33. Lobotesis K, Fenwick JD, Phipps A, Ryman A, Swann A, Ballard C, et al. (2001) Occipital hypoperfusion on SPECT in dementia with Lewy bodies but not AD. Neurology 56: 643-649.
34. McKeith I, Mintzer J, Aarsland D, Burn D, Chiu H, Cohen-Mansfield J, et al. (2004) Dementia with Lewy bodies. Lancet Neurol 3: 19-28.
35. McKeith IG, (2006) Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the Consortium on DLB International Workshop. J Alzheimers Dis 9 (Suppl. 3): 417-423.
36. Miners JS, van Helmond Z, Kehoe PG, Love S, (2010) Changes with age in the activities of β-secretase and the Aβ-degrading enzymes neprilysin, insulin-degrading enzyme and angiotensin-converting enzyme. Brain Pathol 20: 794-802.
37. Miners JS, van Helmond Z, Raiker M, Love S, Kehoe PG, (2010) ACE variants and association with brain Aβ levels in Alzheimer's disease. Am J Transl Res 3: 73-80.
38. Miners S, Ashby E, Baig S, Harrison R, Tayler H, Speedy E, et al. (2009) Angiotensin-converting enzyme levels and activity in Alzheimer's disease: differences in brain and CSF ACE and association with ACE1 genotypes. Am J Transl Res 1: 163-177.
39. Niwa K, Kazama K, Younkin SG, Carlson GA, Iadecola C, (2002) Alterations in cerebral blood flow and glucose utilization in mice overexpressing the amyloid precursor protein. Neurobiol Dis 9: 61-68.
40. Niwa K, Porter VA, Kazama K, Cornfield D, Carlson GA, Iadecola C, (2001) A β-peptides enhance vasoconstriction in cerebral circulation. Am J Physiol Heart Circ Physiol 281: H2417-H2424.
41. Nor JE, Christensen J, Mooney DJ, Polverini PJ, (1999) Vascular endothelial growth factor (VEGF)-mediated angiogenesis is associated with enhanced endothelial cell survival and induction of Bcl-2 expression. Am J Pathol 154: 375-384.
42. Paleologou KE, Schmid AW, Rospigliosi CC, Kim HY, Lamberto GR, Fredenburg RA, et al. (2008) Phosphorylation at Ser-129 but not the phosphomimics S129E/D inhibits the fibrillation of α-synuclein. J Biol Chem 283: 16895-16905.
43. Palmer JC, Baig S, Kehoe PG, Love S, (2009) Endothelin-converting enzyme-2 is increased in Alzheimer's disease and up-regulated by Aβ. Am J Pathol 175: 262-270.
44. Palmer JC, Barker R, Kehoe PG, Love S, (2012) Endothelin-1 is elevated in Alzheimer's disease and upregulated by amyloid-β. J Alzheimers Dis 29: 853-861.
45. Palmer JC, Kehoe PG, Love S, (2010) Endothelin-converting enzyme-1 in Alzheimer's disease and vascular dementia. Neuropathol Appl Neurobiol 36: 487-497.
46. Paxinou E, Chen Q, Weisse M, Giasson BI, Norris EH, Rueter SM, et al. (2001) Induction of α-synuclein aggregation by intracellular nitrative insult. J Neurosci 21: 8053-8061.
47. Pugh CW, Ratcliffe PJ, (2003) Regulation of angiogenesis by hypoxia: role of the HIF system. Nat Med 9: 677-684.
48. Rivard A, Fabre JE, Silver M, Chen D, Murohara T, Kearney M, et al. (1999) Age-dependent impairment of angiogenesis. Circulation 99: 111-120.
49. Rosenstein JM, Krum JM, (2004) New roles for VEGF in nervous tissue-beyond blood vessels. Exp Neurol 187: 246-253.
50. Ruitenberg A, den Heijer T, Bakker SL, van Swieten JC, Koudstaal PJ, Hofman A, Breteler MM, (2005) Cerebral hypoperfusion and clinical onset of dementia: the Rotterdam Study. Ann Neurol 57: 789-794.
51. Sondell M, Lundborg G, Kanje M, (1999) Vascular endothelial growth factor has neurotrophic activity and stimulates axonal outgrowth, enhancing cell survival and Schwann cell proliferation in the peripheral nervous system. J Neurosci 19: 5731-5740.
52. Sondell M, Sundler F, Kanje M, (2000) Vascular endothelial growth factor is a neurotrophic factor which stimulates axonal outgrowth through the flk-1 receptor. Eur J Neurosci 12: 4243-4254.
53. Takahashi M, Ko LW, Kulathingal J, Jiang P, Sevlever D, Yen SH, (2007) Oxidative stress-induced phosphorylation, degradation and aggregation of α-synuclein are linked to upregulated CK2 and cathepsin D. Eur J Neurosci 26: 863-874.
54. Tarkowski E, Issa R, Sjogren M, Wallin A, Blennow K, Tarkowski A, Kumar P, (2002) Increased intrathecal levels of the angiogenic factors VEGF and TGF-β in Alzheimer's disease and vascular dementia. Neurobiol Aging 23: 237-243.
55. Unal-Cevik I, Gursoy-Ozdemir Y, Yemisci M, Lule S, Gurer G, Can A, et al. (2011) -synuclein aggregation induced by brief ischemia negatively impacts neuronal survival in vivo: a study in [A30P]α-synuclein transgenic mouse. J Cereb Blood Flow Metab 31: 913-923.
56. van Helmond Z, Miners JS, Kehoe PG, Love S, (2010) Higher soluble amyloid β concentration in frontal cortex of young adults than in normal elderly or Alzheimer's disease. Brain Pathol 20: 787-793.
57. van Helmond Z, Miners JS, Kehoe PG, Love S, (2010) Oligomeric Aβ in Alzheimer's disease: relationship to plaque and tangle pathology, APOE genotype and cerebral amyloid angiopathy. Brain Pathol 20: 468-480.
58. van Helmond ZK, Miners JS, Bednall E, Chalmers KA, Zhang Y, Wilcock GK, et al. (2007) Caveolin-1 and -2 and their relationship to cerebral amyloid angiopathy in Alzheimer's disease. Neuropathol Appl Neurobiol 33: 317-327.
59. Wada K, Arai H, Takanashi M, Fukae J, Oizumi H, Yasuda T, et al. (2006) Expression levels of vascular endothelial growth factor and its receptors in Parkinson's disease. Neuroreport 17: 705-709.
60. Weiner MF, (1999) Dementia associated with Lewy bodies: dilemmas and directions. Arch Neurol 56: 1441-1442.
61. Yoon DK, Hwang IK, Yoo KY, Lee YB, Lee JJ, Kim JH, et al. (2006) Comparison of α-synuclein immunoreactivity and protein levels in ischemic hippocampal CA1 region between adult and aged gerbils and correlation with Cu,Zn-superoxide dismutase. Neurosci Res 55: 434-441.
62. Yu S, Liu XM, Li YH, Lu GW, Chen B, (2004) [Effect of repeated acute hypoxic treatment on the expression of α-synuclein in the mouse brain cortex]. Sheng Li Xue Bao 56: 263-268.
63. Zhang X, Zhou K, Wang R, Cui J, Lipton SA, Liao FF, et al. (2007) Hypoxia-inducible factor 1α (HIF-1α)-mediated hypoxia increases BACE1 expression and β-amyloid generation. J Biol Chem 282: 10873-10880.
64. Zhang ZG, Zhang L, Jiang Q, Zhang R, Davies K, Powers C, et al. (2000) VEGF enhances angiogenesis and promotes blood-brain barrier leakage in the ischemic brain. J Clin Invest 106: 829-838.
65. Zhiyou C, Yong Y, Shanquan S, Jun Z, Liangguo H, Ling Y, Jieying L, (2009) Upregulation of BACE1 and β-amyloid protein mediated by chronic cerebral hypoperfusion contributes to cognitive impairment and pathogenesis of Alzheimer's disease. Neurochem Res 34: 1226-1235.